Lea Stevnsborg, Magnus Pedersen, Lilli Kirkeskov, Per Føge Jensen, Merete Osler
{"title":"Chronic Pain and Labour Market Affiliation: Effect of Demographic Factors and Comorbidities 5 Years Before and 2 Years After Multidisciplinary Treatment","authors":"Lea Stevnsborg, Magnus Pedersen, Lilli Kirkeskov, Per Føge Jensen, Merete Osler","doi":"10.1002/ejp.70135","DOIUrl":"https://doi.org/10.1002/ejp.70135","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Purpose</h3>\u0000 \u0000 <p>This study investigates the association of sociodemographic factors and comorbidities with labour market affiliation among patients with non-malignant chronic pain treated at multidisciplinary pain centres in Denmark.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This registry-based cohort study used data from the nationwide Danish Civil Registration System and Danish National Patient Registry. Patients treated at multidisciplinary pain centres in 2013–2017 were included. Labour market affiliation was assessed 5 years before and 2 years after treatment and at treatment initiation (baseline). Sequence and logistic regression analyses were used to identify associations.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>2375 patients (median age 47 years, female 64%, comorbidity: Mean Charlson's comorbidity score: 0.88, affective disorder: 45%, anxiety disorder: 37.0%, personality disorder: 7.8%) were included. At treatment initiation, only 34.2% of patients were employed, compared to 58.6% 5 years before treatment. Sequence analysis revealed that most patients remained in or transitioned to a ‘no labour market affiliation’ state. Factors significantly associated with labour market affiliation across timepoints included age (adjusted odd ratio [aOR] and 95% confidence interval [CI]<sub>age 56–65</sub> = 0.51 [0.38–0.69]), marital status (aOR<sub>cohabitant</sub> = 1.58 [1.30–1.92]), education level (aOR<sub>high</sub> = 4.56 [3.51–5.93]), immigrant status (aOR<sub>non-western</sub> = 0.35 [0.26–0.45]) and psychiatric comorbidities (aOR<sub>affective disorders</sub> = 0.67 [0.56–0.87]).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Patients with high-impact, treatment-resistant chronic pain face early labour market detachment, highlighting the need for timely, equitable interventions to support employment, especially among vulnerable groups.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Significance Statement</h3>\u0000 \u0000 <p>The study offers new evidence on how socioeconomic and psychiatric comorbid vulnerabilities shape long-term labour market affiliation before relevant multidisciplinary treatment is initiated and suggests that key intervention opportunities for at-risk patients may be missed under current practice.</p>\u0000 </section>\u0000 </div>","PeriodicalId":12021,"journal":{"name":"European Journal of Pain","volume":"29 10","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejp.70135","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145146732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zi-Min Cao, Jing-Nan Jia, Guo-Yun Liu, Ze-Qiu Yang, Jing-Shi Zhang, An-qi Shi, Yi-Chao Chen, Jian-Wei Huo, Ya-Nan Zhang, Ni Liu, Chao-Qun Yan, Jun Wang
{"title":"Altered Topology of Brain Structural Network in Patients With Migraine Without Aura: A Structural MRI Study","authors":"Zi-Min Cao, Jing-Nan Jia, Guo-Yun Liu, Ze-Qiu Yang, Jing-Shi Zhang, An-qi Shi, Yi-Chao Chen, Jian-Wei Huo, Ya-Nan Zhang, Ni Liu, Chao-Qun Yan, Jun Wang","doi":"10.1002/ejp.70129","DOIUrl":"10.1002/ejp.70129","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Migraine is a neurovascular disease associated with significant morbidity and disability, but its underlying pathophysiology remains elusive. Functional alterations within the brain are frequently observed in individuals with migraine, whereas structural changes are less frequently documented. This study was primarily designed to investigate topological abnormalities in brain structural networks in patients with migraine using structural magnetic resonance imaging.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Graph theoretical analysis was used to compare global and regional topological properties of grey matter structural networks in 37 migraine patients and 44 age-, gender-, and education-matched healthy controls. Structural correlation networks were constructed for both groups on the basis of measurements of grey matter volume.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A statistically significant difference was observed in the scores of Self-rating Anxiety Scales (SAS) and Self-rating Depression Scales (SDS) between migraine patients and healthy controls. The brain networks of patients exhibited significantly increased path length, decreased clustering coefficient, and small-worldness at the global level. At the regional level, brain regions with changes in node degree/betweenness centrality in migraine patients were predominantly located in the left cuneus, the left fusiform gyrus, the left precuneus, the right precentral gyrus, the right middle frontal gyrus, and the bilateral lingual gyrus.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The findings of this research indicate that the topological organisation is less efficient in individuals who experience migraine. This may provide new insight into the pathogenesis of migraine from a structural perspective.</p>\u0000 \u0000 <p><b>Trial Registration:</b> Chinese Clinical Trial Registry, ChiCTR2000033995</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Significance</h3>\u0000 \u0000 <p>The present study addresses the central pathogenesis of migraine and shows at a structural level that global brain properties are altered in migraine patients and that regional properties of specific brain regions also show abnormalities. This provides new ideas and an objective basis for the future diagnosis and treatment of migraine.</p>\u0000 </section>\u0000 </div>","PeriodicalId":12021,"journal":{"name":"European Journal of Pain","volume":"29 10","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejp.70129","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145136981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Performance-Related Pain Among Professional Orchestra Musicians—The First Portuguese Nationwide Study (POMPS)","authors":"A. Zão, E. Altennmüller, L. Azevedo","doi":"10.1002/ejp.70124","DOIUrl":"10.1002/ejp.70124","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Pain is a major health problem among musicians. However, data concerning pain in a nationwide perspective are scarce, particularly among Portuguese musicians. Therefore, we aim to evaluate performance-related pain among professional orchestra musicians throughout a nationwide characterisation of all Portuguese orchestras.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We performed a multicenter cross-sectional study involving all Portuguese professional orchestras, which included 432 musicians (response rate of 72.1%). The main outcome was performance-related pain (evaluated by the Performance-related Pain among Musicians Questionnaire—PPAM). The secondary outcomes were: pain approach, physical activity levels, fatigue, distress, perfectionism, and health-related quality of life. We calculated the prevalence of PRP and performed a descriptive analysis of the main characteristics of our sample (distinguishing musicians with and without PRP) and of PRP, fatigue, distress, perfectionism, and health-related quality of life among musicians with pain, comparing full-time and partial-time musicians.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The lifetime and point prevalence of performance-related pain were 71.8% and 33.3%, respectively. Pain intensity score was 14.9 (out of 40), pain interference in general activities was 21.8 (out of 70) and pain interference in performance was even higher (28.3 out of 50). Pain intensity and interference, fatigue, and perfectionism were higher, and quality of life was lower among full-time musicians. Pain was significantly more prevalent among full-time musicians, string instrumentalists, older and more sedentary musicians, with longer careers, and those who play more hours per week. Multivariate logistic regression defined a model containing five factors significantly associated with higher probability of performance-related pain.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>We highlight the high prevalence of pain and the significant negative impact of pain on performance and quality of life.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Significance Statement</h3>\u0000 \u0000 <p>This first Portuguese nationwide study demonstrated that pain is a highly disabling condition among professional orchestra musicians, particularly among full-time musicians, supporting the integration of healthcare professionals in the professional orchestra framework for a closed follow-up, early assessment and treatment,","PeriodicalId":12021,"journal":{"name":"European Journal of Pain","volume":"29 10","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejp.70124","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145136966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Xavier Moisset, M. Gabrielle Pagé, Bruno Pereira, Manon Choinière
{"title":"Patient Subgroups and Predictors of Improvement in Chronic Neuropathic Pain: A Trajectory-Based Analysis","authors":"Xavier Moisset, M. Gabrielle Pagé, Bruno Pereira, Manon Choinière","doi":"10.1002/ejp.70137","DOIUrl":"10.1002/ejp.70137","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>There is limited real-world evidence on predictive factors for good outcomes in patients with chronic neuropathic pain (NP) treated in multidisciplinary tertiary care centres. This study aimed to identify subgroups of NP patients with similar pain trajectories and evaluate associated factors.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We analysed data from 912 patients with chronic NP (age: 53.6 ± 13.3 years; 51.5% female) enrolled in the Quebec Pain Registry, all of whom reported a baseline pain intensity of ≥ 4/10. Patients completed standardised questionnaires prior to treatment initiation, as well as at 6 and 12 months. Pain trajectories were identified using group-based trajectory modelling (GBTM), with multiple imputation performed to address missing data. The results were confirmed using group-mixture modelling on the non-imputed dataset and using GBTM in the subgroup of patients with complete data.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A three-class trajectory model best fitted the data for both pain intensity and interference. Only 23.1% of patients showed a clear improvement in pain intensity, while 23.5% showed improvement in pain interference. Key predictors of pain intensity improvement included lower baseline pain intensity and interference. Improvement in pain interference was associated with lower baseline interference and depression scores, as well as shorter pain duration. Notably, receiving a strong opioid significantly increased the risk (RR = 1.45 [1.17; 1.78]) of belonging to the persisting severe pain trajectory.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>A minority of chronic NP patients demonstrated significant improvement with multidisciplinary treatment. These findings highlight the limitations of current management strategies and emphasise the need for novel therapeutic approaches to address the burden of chronic NP effectively.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Significance</h3>\u0000 \u0000 <p>This study highlights the value of trajectory analysis in identifying subgroups of patients with chronic neuropathic pain (NP) who exhibit different patterns of treatment response. Only a minority of patients—approximately 23% for both pain intensity and pain interference—demonstrated meaningful improvement. Lower baseline pain intensity and interference emerged as key predictors of better outcomes, while strong opioid use was associated with persistent severe pain. These findings undersco","PeriodicalId":12021,"journal":{"name":"European Journal of Pain","volume":"29 10","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejp.70137","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145130445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rafael Batista João, Jilly Octoria Tagore Chan, André Batista João, Luísa Mendes Araújo, Julyana Medeiros Dantas
{"title":"Mirogabalin for Treatment of Neuropathic Pain and Associated Sleep Interference: An Updated Meta-Analysis","authors":"Rafael Batista João, Jilly Octoria Tagore Chan, André Batista João, Luísa Mendes Araújo, Julyana Medeiros Dantas","doi":"10.1002/ejp.70112","DOIUrl":"10.1002/ejp.70112","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background and Objective</h3>\u0000 \u0000 <p>Neuropathic pain (NeP) is a common and debilitating consequence of several neurological conditions. Gabapentinoids are used on a large scale for the treatment of both central and peripheral NeP. Mirogabalin, a novel gabapentinoid, has been proposed as a promising treatment for this condition; however, its efficacy and safety profile still need to be determined in clinical practice. In this systematic review and meta-analysis, we assessed the efficacy on pain intensity reduction, effects on sleep interference by pain, and safety of mirogabalin compared with placebo in patients affected by NeP.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Databases and Data Treatment</h3>\u0000 \u0000 <p>We searched PubMed, Cochrane Library, Embase, Web of Science, and ClinicalTrials.gov databases for randomised controlled trials (RCTs) comparing mirogabalin with placebo in patients experiencing central or peripheral NeP. We computed mean differences (MD) and pooled risk ratios (RR) for continuous and binary outcomes, respectively, with 95% confidence intervals (CI). Pain was measured on a 0 to 10 numerical rating scale.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>We included 6 RCTs involving 3048 patients. The mean age was 60.6 years, and 64.7% were male. When compared with placebo, patients treated with mirogabalin had a significant decrease in average daily pain (MD −0.60; 95% CI −0.75 to −0.45; <i>p</i> < 0.001) and in pain-related sleep interference scores (MD −0.66; 95% CI −0.81 to −0.51; <i>p</i> < 0.001). The mirogabalin group showed a higher rate of substantial pain relief (≥ 50%) compared with the placebo group (RR 1.27; 95% CI 1.10 to 1.46; <i>p</i> = 0.001). Nonetheless, treatment with mirogabalin increased the risk of weight gain, peripheral oedema, somnolence and dizziness.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>In this meta-analysis of RCTs evaluating patients with central and peripheral NeP, mirogabalin significantly improved pain and decreased sleep interference by pain, as compared with placebo; however, there was an increased risk of adverse events.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Significance</h3>\u0000 \u0000 <p>This meta-analysis refines the current understanding of mirogabalin by demonstrating modest yet consistent benefits in reducing pain and pain-related sleep interference across neuropathic pain syndromes. The results contribute to ongoing efforts to optimise neuropathic pain management and provide more robust e","PeriodicalId":12021,"journal":{"name":"European Journal of Pain","volume":"29 10","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejp.70112","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145085616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Haya Al Sharaa, Sara Laureen Bartels, Afra S. Taygar, Linnéa Engman, Suzanne Petersson, Ida Flink, Katja Boersma, Lance M. McCracken, Laura Simons, Johan W. S. Vlaeyen, Patrick Onghena, Rikard K. Wicksell
{"title":"Individual-Level Effects of a Digital Behavioural Treatment for Chronic Pain: Proof-of-Concept of a Single-Case Experimental Design Study","authors":"Haya Al Sharaa, Sara Laureen Bartels, Afra S. Taygar, Linnéa Engman, Suzanne Petersson, Ida Flink, Katja Boersma, Lance M. McCracken, Laura Simons, Johan W. S. Vlaeyen, Patrick Onghena, Rikard K. Wicksell","doi":"10.1002/ejp.70128","DOIUrl":"10.1002/ejp.70128","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Chronic pain affects 20%–30% of the population worldwide, leading to significant distress, disability and financial burden. Pain management strategies focusing on pain reduction have shown limited effects on functioning; however, behavioural treatments aimed at enhancing resilience have demonstrated strong empirical support. Digital solutions offer new opportunities for delivering evidence-based treatments, but evaluation at the individual level is needed. The aim of this study is to examine individual-level treatment effects of a digital behavioural treatment for chronic pain in a heterogeneous sample.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A study with a single-case experimental design (SCED) was conducted with participants (<i>N</i> = 11) experiencing chronic pain (> 3 months) recruited through healthcare. Participants were randomised at baseline (5–10-day A-phase) and completed a 6-module digital treatment based on learning theory and well-established theories applied to chronic pain (6–8-week B-phase), with weekly therapist contact. Digital diaries, prompted twice daily, tracked psychological flexibility and acceptance, pain-related functioning, pain intensity and well-being. Data were analysed using visual analysis and effect size calculations.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p><i>N</i> = 11 enrolled and data from <i>n</i> = 10 were analysed (<i>n</i> = 1 refused digital diary, <i>n</i> = 2 partial completers, <i>n</i> = 8 full completers). Pain profiles varied (e.g., chronic migraine, fibromyalgia, lower back pain, etc.). Several participants benefited from the treatment, though results varied across individuals and across outcomes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The digital behavioural treatment showed promise in addressing diverse pain profiles and associated functioning. The variability in responses highlights the benefit of using SCED to explore individual-level effects, thus offering a methodological proof-of-concept. Findings support further development, including tailoring to match individual needs.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Significance Statement</h3>\u0000 \u0000 <p>This proof-of-concept study provides support for the utility of digital behavioural interventions and individual-level evaluation of treatment effects, highlighting the potential of personalised pain treatments. The findings contribute to the growing body of support for digital solutions as effective ","PeriodicalId":12021,"journal":{"name":"European Journal of Pain","volume":"29 10","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12444821/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145079980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jenna L. Adamowicz, Alexis Grant, Collin Calvert, Daniel Elchert, Katherine Hadlandsmyth, Mary A. Driscoll, Stephanie L. Taylor, Kelli Allen, Brent C. Taylor, Diana J. Burgess
{"title":"Differences Among Veterans With Chronic Overlapping Pain Conditions and Other Chronic Pain: Baseline Results From the LAMP Pain Management Trial","authors":"Jenna L. Adamowicz, Alexis Grant, Collin Calvert, Daniel Elchert, Katherine Hadlandsmyth, Mary A. Driscoll, Stephanie L. Taylor, Kelli Allen, Brent C. Taylor, Diana J. Burgess","doi":"10.1002/ejp.70125","DOIUrl":"https://doi.org/10.1002/ejp.70125","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Chronic overlapping pain conditions (COPCs) are a constellation of disorders posited to share an underlying pain mechanism (nociplastic pain). Unfortunately, individuals with COPCs are under-represented in clinical research. The current study aimed to determine COPC prevalence among participants enrolled in a pragmatic clinical trial and compare those with COPCs to those with non-COPCs across several domains.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Learning to Apply Mindfulness to Pain (LAMP) study baseline data of veterans with chronic pain (<i>N</i> = 811) were utilised. COPC diagnoses were determined using ICD-10 codes within electronic health records. Group differences across pain and functioning-related domains were compared with and without adjustment for age and gender.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among participants with COPCs (54%), most were diagnosed with only one COPC (74%). Chronic lower back pain (71%) and migraine (28%) were the most common. Participants with COPCs were younger and more likely to be female relative to those with non-COPCs. The COPC subset was also more likely to be diagnosed with PTSD, depressive disorders and sleep disorders (<i>p</i> < 0.05). Those with COPCs also reported greater pain severity and interference, more impaired health-related quality of life, greater pain catastrophising and lower pain self-efficacy than participants without COPCs (<i>p</i> < 0.05).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>COPCs were common among a sample of veterans in a pragmatic clinical trial. Several baseline differences emerged indicating veterans with COPCs experience greater mental health concerns and endorse distinct pain characteristics and pain mediators. Future research is needed to further characterise this recently defined and under-represented group.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Significance Statement</h3>\u0000 \u0000 <p>Individuals with COPCs are medically complex, yet are understudied and underrepresented within pain trials research. COPCs, which predominantly impact women, are also understudied within U.S. veterans. Our findings highlight how veterans with COPCs are participating in clinical research even when interventions are not tailored to their unique characteristics. Our work also contributes to a nuanced understanding of this disease burden and is among the first to describe differences among veterans with COPCs and veterans with chronic pain but without COPCs.</p>\u0000 </section>\u0000 </div>","PeriodicalId":12021,"journal":{"name":"European Journal of Pain","volume":"29 9","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145062426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Julien Nizard, Marie Faure, Nadine Attal, Jean-Paul Nguyen, Pierre-Henri Garnier, Rolland Peyron, Didier Bouhassira, Pierre Nizet, Jean-Pascal Lefaucheur
{"title":"Perception and Impact of Transcranial Magnetic Stimulation in Patients With Chronic Neuropathic Pain: A Longitudinal Qualitative Study","authors":"Julien Nizard, Marie Faure, Nadine Attal, Jean-Paul Nguyen, Pierre-Henri Garnier, Rolland Peyron, Didier Bouhassira, Pierre Nizet, Jean-Pascal Lefaucheur","doi":"10.1002/ejp.70127","DOIUrl":"https://doi.org/10.1002/ejp.70127","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Repetitive transcranial magnetic stimulation (rTMS) is recommended as a third-line treatment for chronic neuropathic pain. Because of its non-invasive nature and limited side effects, it is considered a good therapeutic option. rTMS efficacy on chronic neuropathic pain has been demonstrated in numerous quantitative studies. However, there are no qualitative studies to support these quantitative data.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Included patients presented with peripheral neuropathic pain related to polyneuropathy (<i>n</i> = 6), radiculopathy (<i>n</i> = 3) and traumatic or surgical nerve injury (<i>n</i> = 3). The target of the rTMS was the primary motor cortex. We conducted a longitudinal qualitative study consisting of two separate semi-structured interviews for all 12 participants from four different French multidisciplinary pain centres, one before starting treatment and the other after 2 months of rTMS treatment. Two separate manual analyses by two researchers were carried out, as were software analysis and data triangulation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Our study revealed an overall positive impression about rTMS treatment, with improvements in pain and activities of daily living. However, most participants felt that information on this treatment was inadequate because of difficulties in understanding the treatment mechanism. These difficulties frequently led to misrepresentations about the treatment, which could result in secondary fears, particularly in relation to the fear of cognitive capacity loss.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The results suggest possible areas for improvement, both in clinical practice and in care organisation. Information provided to patients could be optimised, with a focus on more personalised care, considering preliminary representations and fears, so as to further encourage adherence to treatment. Furthermore, it is necessary to train healthcare staff in order to optimise the care pathway for patients suffering from intractable chronic pain and to limit the risks of delays in treatment.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Significance Statement</h3>\u0000 \u0000 <p>rTMS treatment showed overall positive effects on pain and quality of life. Many participants lacked clear understanding of the treatment mechanism, leading to fear and misinformation. Improvements are needed in patient education and healthcare staff training to support therapy compliance and optimise care.</p>\u0000 </section>\u0000 </div>","PeriodicalId":12021,"journal":{"name":"European Journal of Pain","volume":"29 9","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145062427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frank Lobbezoo, Birgitta Häggman-Henrikson, Merel C. Verhoeff, Ghizlane Aarab, Jari Ahlberg, Per Alstergren, Lene Baad-Hansen, Rosaria Bucci, Iacopo Cioffi, Adeyinka F. Dayo, Justin Durham, Zhengfei Huang, Michail Koutris, Anna Lövgren, Daniele Manfredini, Ambra Michelotti, Donald R. Nixdorf, Juan F. Oyarzo, Christopher C. Peck, Maria Pigg, Peter Svensson, Ana Velly, Corine M. Visscher, Peter Wetselaar, Barry J. Sessle, Orofacial and Head Pain Special Interest Group (SIG) of the International Association for the Study of Pain (IASP), International Network for Orofacial Pain and Related Disorders Methodology (INfORM) of the International Association for Dental, Oral and Craniofacial Research (IADR)
{"title":"All Hands on Deck—Let's Not Forget About Orofacial Pain in Low- and Middle-Income Settings","authors":"Frank Lobbezoo, Birgitta Häggman-Henrikson, Merel C. Verhoeff, Ghizlane Aarab, Jari Ahlberg, Per Alstergren, Lene Baad-Hansen, Rosaria Bucci, Iacopo Cioffi, Adeyinka F. Dayo, Justin Durham, Zhengfei Huang, Michail Koutris, Anna Lövgren, Daniele Manfredini, Ambra Michelotti, Donald R. Nixdorf, Juan F. Oyarzo, Christopher C. Peck, Maria Pigg, Peter Svensson, Ana Velly, Corine M. Visscher, Peter Wetselaar, Barry J. Sessle, Orofacial and Head Pain Special Interest Group (SIG) of the International Association for the Study of Pain (IASP), International Network for Orofacial Pain and Related Disorders Methodology (INfORM) of the International Association for Dental, Oral and Craniofacial Research (IADR)","doi":"10.1002/ejp.70126","DOIUrl":"https://doi.org/10.1002/ejp.70126","url":null,"abstract":"","PeriodicalId":12021,"journal":{"name":"European Journal of Pain","volume":"29 9","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145062692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}